Skip to main content
Premium Trial:

Request an Annual Quote

Elizabeth Cormier-May

Exosome Diagnostics has appointed Elizabeth Cormier-May as its head of commercial diagnostics. Cormier-May first joined the company this spring, helping to build infrastructure for the launch of Exosome's flagship test, ExoDx Prostate (IntelliScore). She will now lead the firm in building out what it hopes will become a much more extensive diagnostic menu. Cormier-May has thirteen years of experience in medicinal chemistry, genetics, and companion and molecular diagnostics development. Prior to joining Exosome, she worked with other MDx firms including Myriad Genetics, Qiagen, and Predictive Biosciences, as well as in companion diagnostic development with pharmaceutical companies. She holds a bachelor’s degree in organic chemistry from Wheaton College, and attended graduate school for organic chemistry and chemical biology at Northeastern University.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.